News

Bavarian Nordic said the multicentre, randomised Phase II study will compare Prostvac followed by docetaxel (chemotherapy) versus docetaxel alone. Patients in the Prostvac arm will receive an accelerated

The dose-escalation Phase I trial will evaluate the safety profile, pharmacokinetics and antitumour activity of brentuximab vedotin when administered sequentially or in combination with multi-agent front-line chemotherapy regimens.

The companies filed the lawsuit in the US District Court for the Southern District of New York and the US District Court for the District of Vermont. Reportedly,

Cenicriviroc (TBR-652) is a potent antagonist of CCR5, a co-receptor needed for HIV infection, and CCR2, another co-receptor prominently involved in several metabolic and cardiovascular diseases. Findings have

Study findings demonstrated that the gel, when applied to the vagina in previous trials, reduced HIV infection by 34% compared with placebo, which urged researchers to find out

The certifications confirm that the systems are capable of performing the required functions to help users comply with Stage 1 Meaningful Use measures that eligible providers must meet

Operating loss for the fourth quarter of 2010 was EUR198.94m, compared to EUR7.93m for the same period in 2009. Intercell has generated gross profit was EUR7.63m, compared to

As per the terms of the transaction, each outstanding share of King Pharma common stock has been converted into the right to receive $14.25, net in cash (without

Valeritas has examined Humalog and NovoLog and found safe for use with the V-Go Disposable Insulin Delivery Device. The V-Go is small, lightweight, and worn under the patients’